Mengting Ding

713 total citations
31 papers, 290 citations indexed

About

Mengting Ding is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Mengting Ding has authored 31 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Cancer Research. Recurrent topics in Mengting Ding's work include Bladder and Urothelial Cancer Treatments (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Mengting Ding is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Mengting Ding collaborates with scholars based in China, United States and Canada. Mengting Ding's co-authors include Yuchen Liu, Yuhan Liu, Hengji Zhan, Weiren Huang, Xinhui Liao, Qunjun Gao, Zhiming Cai, Qun Zhou, Qian Zhou and Jiaxing Lin and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Water Research.

In The Last Decade

Mengting Ding

28 papers receiving 289 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mengting Ding 157 92 32 24 22 31 290
Huadong Qin 127 0.8× 92 1.0× 27 0.8× 13 0.5× 38 1.7× 21 397
Li Xl 136 0.9× 80 0.9× 26 0.8× 23 1.0× 33 1.5× 40 333
Jinyang Wang 161 1.0× 94 1.0× 14 0.4× 12 0.5× 19 0.9× 44 425
Ji Wu 196 1.2× 168 1.8× 25 0.8× 21 0.9× 39 1.8× 33 466
Boyu Yang 179 1.1× 125 1.4× 26 0.8× 16 0.7× 11 0.5× 20 339
Jinzhi Wu 93 0.6× 35 0.4× 21 0.7× 27 1.1× 27 1.2× 34 255
Yingying Zheng 87 0.6× 45 0.5× 23 0.7× 23 1.0× 14 0.6× 28 297
Mingxia Zheng 123 0.8× 87 0.9× 19 0.6× 17 0.7× 30 1.4× 30 285
Mingli Hu 367 2.3× 123 1.3× 29 0.9× 25 1.0× 16 0.7× 28 530

Countries citing papers authored by Mengting Ding

Since Specialization
Citations

This map shows the geographic impact of Mengting Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengting Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengting Ding more than expected).

Fields of papers citing papers by Mengting Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengting Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengting Ding. The network helps show where Mengting Ding may publish in the future.

Co-authorship network of co-authors of Mengting Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Mengting Ding. A scholar is included among the top collaborators of Mengting Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengting Ding. Mengting Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ding, Mengting, et al.. (2025). The importance of intravesical bacteria in bladder cancer recurrence and the value of tumor treating fields. Medical Hypotheses. 204. 111782–111782.
2.
Peng, Yun, Caipeng Qin, Mengting Ding, et al.. (2025). Genomic subtypes of non-muscle-invasive bladder cancer: guiding immunotherapy decision-making for patients exposed to aristolochic acid. Molecular Medicine. 31(1). 140–140. 1 indexed citations
3.
Ding, Mengting, Jiaxing Lin, Yiqing Du, et al.. (2024). Novel CAR‐T Cells Specifically Targeting SIA‐CIgG Demonstrate Effective Antitumor Efficacy in Bladder Cancer. Advanced Science. 11(40). e2400156–e2400156. 9 indexed citations
4.
Yan-hu, Liu, Yibo Wang, Jiani Sun, et al.. (2024). iDog: a multi-omics resource for canids study. Nucleic Acids Research. 53(D1). D1039–D1046. 1 indexed citations
5.
Ding, Mengting, Di Wang, Hui Li, et al.. (2024). Chemical diversity and antimelanoma potential of rosemary essential oils: Unveiling mechanistic insights through quantitative proteomics. Industrial Crops and Products. 215. 118652–118652. 3 indexed citations
6.
Zhou, Qian, et al.. (2024). Stability and performance of aerobic granular sludge for treatment of textile-dyeing wastewater. Journal of Water Process Engineering. 63. 105401–105401. 10 indexed citations
7.
8.
Zhou, Qian, et al.. (2024). Effects of iron-carbon on nitrogen metabolism of floc and aerobic granular sludge. Bioresource Technology. 413. 131376–131376. 3 indexed citations
9.
10.
Zhang, Lin, Mengting Ding, Xiaoxin Sun, et al.. (2023). CD56 polysialylation promotes the tumorigenesis and progression via the Hedgehog and Wnt/β-catenin signaling pathways in clear cell renal cell carcinoma. Cancer Cell International. 23(1). 319–319. 7 indexed citations
11.
Xu, Heran, Mengting Ding, Jingyi Li, et al.. (2023). Screening of Rosemary Essential Oils with Different Phytochemicals for Antioxidant Capacity, Keratinocyte Cytotoxicity, and Anti-Proliferative Activity. Molecules. 28(2). 586–586. 17 indexed citations
12.
Lin, Jiaxing, Mengting Ding, Caipeng Qin, et al.. (2023). A robust gene prognostic index composed of GZMB, IRF1, and TP63 can stratify the risk of two metastatic urothelial carcinoma cohorts based on immune checkpoint blockade therapy. Journal of Cancer Research and Clinical Oncology. 149(12). 9877–9890.
13.
Yang, Wenbo, et al.. (2022). Intratumoral fibrosis and patterns of immune infiltration in clear cell renal cell carcinoma. BMC Cancer. 22(1). 661–661. 4 indexed citations
14.
Song, Yuxuan, Yiqing Du, Caipeng Qin, et al.. (2022). Gemcitabine-Resistant Biomarkers in Bladder Cancer are Associated with Tumor-Immune Microenvironment. Frontiers in Cell and Developmental Biology. 9. 809620–809620. 12 indexed citations
15.
Ding, Mengting, Yuhan Liu, Yuhan Liu, et al.. (2018). Oestrogen promotes tumorigenesis of bladder cancer by inducing the enhancer RNA—eGREB1. Journal of Cellular and Molecular Medicine. 22(12). 5919–5927. 13 indexed citations
16.
Xie, Haibiao, Hengji Zhan, Qunjun Gao, et al.. (2018). Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells. Cancer Letters. 422. 94–106. 9 indexed citations
17.
Zhou, Qun, Hengji Zhan, Fang Lan, et al.. (2018). A revolutionary tool: CRISPR technology plays an important role in construction of intelligentized gene circuits. Cell Proliferation. 52(2). e12552–e12552. 11 indexed citations
18.
Ding, Mengting, Hengji Zhan, Xinhui Liao, et al.. (2018). Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer. International Journal of Biological Sciences. 14(10). 1268–1276. 20 indexed citations
19.
Gao, Qunjun, Yuhan Liu, Haibiao Xie, et al.. (2018). Lentivirus-mediated shRNA targeting <em>MUTYH</em> inhibits malignant phenotypes of bladder cancer SW780 cells. OncoTargets and Therapy. Volume 11. 6101–6109. 7 indexed citations
20.
Ding, Mengting, Yuhan Liu, Xinhui Liao, et al.. (2018). Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment. Journal of Cancer. 9(13). 2334–2340. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huadong Qin Breakdown of academic impact, for papers by Li Xl Breakdown of academic impact, for papers by Jinyang Wang Breakdown of academic impact, for papers by Ji Wu Breakdown of academic impact, for papers by Boyu Yang Breakdown of academic impact, for papers by Jinzhi Wu Breakdown of academic impact, for papers by Yingying Zheng Breakdown of academic impact, for papers by Mingxia Zheng Breakdown of academic impact, for papers by Mingli Hu
Rankless by CCL
2026